Company Description
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips.
It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.
In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services.
The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
| Country | United States |
| Founded | 1904 |
| IPO Date | May 17, 2019 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 13,500 |
| CEO | Michael Stubblefield |
Contact Details
Address: Radnor Corporate Center, Building One Radnor, Pennsylvania 19087 United States | |
| Phone | 610 386 1700 |
| Website | avantorsciences.com |
Stock Details
| Ticker Symbol | AVTR |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $14.00 |
| CIK Code | 0001722482 |
| CUSIP Number | 05352A100 |
| ISIN Number | US05352A1007 |
| Employer ID | 82-2758923 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Michael Stubblefield | President, Chief Executive Officer and Director |
| R. Brent Jones | Executive Vice President and Chief Financial Officer |
| Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal and Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2025 | SD | Form - SD |
| May 12, 2025 | 8-K | Current Report |
| Apr 28, 2025 | 8-K | Current Report |
| Apr 25, 2025 | 10-Q | Quarterly Report |
| Apr 25, 2025 | 8-K | Current Report |
| Mar 28, 2025 | ARS | Filing |
| Mar 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 28, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 27, 2025 | 144 | Filing |
| Feb 27, 2025 | 144 | Filing |